mesenchym
stem
cell
wide
studi
promot
local
bone
regener
osteonecrosi
femor
head
onfh
previou
studi
observ
dimethyloxaloylglycin
dmog
enhanc
angiogen
osteogen
activ
mesenchym
stem
cell
activ
express
hypoxia
induc
therebi
improv
bone
repair
capac
mesenchym
stem
cell
present
studi
investig
whether
dmog
could
increas
bone
repair
capac
adiposederiv
stem
cell
asc
treatment
onfh
western
blot
analysi
perform
detect
protein
express
asc
treat
differ
concentr
dmog
result
show
dmog
enhanc
express
asc
dosedepend
manner
least
day
furthermor
dmogtreat
asc
transplant
necrot
area
rabbit
model
onfh
treat
diseas
four
week
later
microcomput
tomographi
ct
quantit
analysi
show
necrot
area
regener
dmogtreat
asc
transplant
group
normal
asc
transplant
group
core
decompress
group
untreat
group
histolog
analysi
show
transplant
dmogtreat
asc
clearli
improv
bone
regener
necrot
area
compar
three
group
microct
immunohistochem
analysi
demonstr
revascul
necrot
area
also
increas
significantli
dmogtreat
asc
group
compar
control
group
thu
hypothes
dmog
could
increas
bone
repair
capac
asc
enhanc
express
treatment
onfh
osteonecrosi
femor
head
onfh
patholog
process
primarili
caus
interrupt
local
blood
circul
caus
apoptosi
osteocyt
osseou
tissu
necrosi
lack
effect
therapi
onfh
difficulti
need
overcom
clinic
practic
sever
method
use
treat
earlystag
onfh
drug
therapi
core
decompress
vascular
bone
graft
rotat
osteotomi
howev
clinic
result
method
satisfactori
previou
studi
describ
use
mesenchym
stem
cell
msc
promot
local
bone
repair
heal
msc
pluripot
differenti
sever
lineag
cell
shown
potenc
treatment
numer
ischem
diseas
myocardi
infarct
nerv
injuri
bone
defect
prior
studi
found
implant
msc
necrot
area
femor
head
abl
improv
local
bone
regener
msc
abl
differenti
osteoblast
promot
local
bone
heal
directli
furthermor
msc
abl
secret
growth
factor
vascular
endotheli
growth
factor
vegf
angiopoietin
stromal
cellderiv
factor
basic
fibroblast
growth
factor
angiogen
potenc
promot
local
revascular
therebi
improv
bone
heal
indirectli
hypoxia
induc
key
mediat
adapt
cell
respons
hypoxia
control
express
numer
gene
modul
cell
prolifer
differenti
pluripot
previou
experi
suggest
could
enhanc
osteogen
differenti
msc
express
angiogen
factor
thu
promot
bone
heal
capac
prior
studi
implant
transgen
msc
necrot
area
femor
head
found
treatment
result
improv
osteogen
angiogen
capac
vitro
vivo
lead
better
result
earlystag
onfh
howev
risk
lentiviru
vector
tumorigenesi
serious
consid
clinic
applic
dimethyloxalylglycin
dmog
cell
permeabl
inhibitor
abl
stabil
express
cell
normal
oxygen
tension
therefor
dmog
hypothes
altern
strategi
enhanc
express
msc
previou
studi
demonstr
dmog
could
increas
express
msc
accordingli
enhanc
bone
heal
capac
present
studi
investig
whether
dmog
abl
enhanc
bone
repair
capac
adiposederiv
stem
cell
asc
treat
earlystag
onfh
anim
healthi
new
zealand
rabbit
weigh
kg
age
month
provid
experiment
anim
centr
shanghai
jiao
tong
univers
affili
sixth
peopl
hospit
shanghai
china
anim
maintain
singl
cage
control
temperatur
lightdark
cycl
fed
standard
diet
anim
receiv
human
care
complianc
guid
us
depart
health
care
use
laboratori
anim
experi
protocol
approv
anim
ethic
committe
shanghai
jiao
tong
univers
isol
cultur
asc
primari
asc
harvest
adipos
tissu
new
zealand
rabbit
briefli
anim
anesthet
pentobarbit
sodium
g
sigmaaldrich
merck
kgaa
darmstadt
germani
adipos
tissu
harvest
digest
collagenas
sigmaaldrich
h
complex
filter
nylon
mesh
shanghai
bolt
cloth
manufactur
co
ltd
shanghai
china
centrifug
room
temperatur
min
x
g
cell
resuspend
dulbecco
modifi
eagl
medium
gibco
thermo
fisher
scientif
inc
grand
island
ny
usa
supplement
fetal
bovin
serum
invitrogen
thermo
fisher
scientif
inc
carlsbad
ca
usa
plate
cultur
flask
corn
life
scienc
tewksburi
usa
cell
cultur
humidifi
co
incub
cultur
medium
replac
everi
day
nonadher
cell
remov
cell
passag
approxim
split
subconflu
cell
four
six
passag
use
follow
experi
western
blot
analysi
evalu
influenc
dmog
sigmaaldrich
express
protein
asc
cell
seed
sixwel
plate
cellswel
regular
medium
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
ad
differ
concentr
dmog
day
total
protein
harvest
cultur
cell
accord
standard
protocol
briefli
cell
wash
three
time
pb
sinopharm
chemic
reagent
co
ltd
shanghai
china
solubil
lysi
buffer
thermo
fisher
scientif
inc
waltham
usa
min
lysat
centrifug
x
g
min
supernat
collect
store
protein
concentr
measur
use
bicinchonin
protein
assay
kit
thermo
fisher
scientif
inc
protein
sampl
separ
use
sdspage
biorad
laboratori
inc
hercul
ca
usa
transfer
nitrocellulos
membran
block
nonfat
milk
room
temperatur
h
primari
antibodi
abcam
cambridg
usa
ad
incub
membran
overnight
infraredconjug
secondari
antibodi
abcam
ad
incub
membran
h
room
temperatur
result
membran
scan
odyssey
scanner
licor
bioscienc
lincoln
ne
usa
quantifi
use
odyssey
softwar
version
protein
level
normal
abcam
prepar
transplant
composit
selfassembl
peptid
gel
beavernano
tm
hydrogel
cyagen
bioscienc
inc
guangzhou
china
use
scaffold
load
asc
transplant
composit
prepar
mix
cell
hydrogel
accord
manufactur
protocol
brief
asc
suspend
ml
sucros
solut
sinopharm
chemic
reagent
co
ltd
cell
suspens
mix
hydrogel
equal
volum
pb
slowli
ad
mix
hydrogel
composit
equal
volum
incub
min
room
temperatur
allow
crosslink
dmogtreat
asc
cell
cultur
regular
medium
dmog
h
prior
mix
hydrogel
ensur
asc
continu
expos
dmog
implant
femor
head
dmog
ad
pb
composit
mix
procedur
anim
onfh
model
treatment
protocol
total
new
zealand
rabbit
age
month
use
establish
onfh
model
accord
previous
report
protocol
brief
one
inject
lipopolysaccharid
lp
sigmaaldrich
administ
intraven
day
three
inject
methylprednisolon
mp
mgkg
pfizer
inc
new
york
ny
usa
administ
intramuscularli
day
six
rabbit
die
induct
protocol
inject
onfh
confirm
use
magnet
reson
imag
mri
ge
healthcar
chicago
il
usa
week
last
inject
mp
stage
onfh
evalu
respect
two
experienc
radiologist
blind
fashion
rabbit
earlystag
onfh
randomli
divid
four
group
group
receiv
therapi
serv
control
ii
group
ii
receiv
core
decompress
femor
head
iii
group
iii
receiv
core
decompress
normal
asc
transplant
iv
group
iv
receiv
core
decompress
dmogtreat
asc
transplant
surgic
procedur
perfus
surgic
procedur
perform
previous
report
brief
anim
anesthet
intraven
pentobarbit
later
approach
made
expos
greater
trochant
asept
condit
drill
diamet
mm
insert
flare
greater
trochant
necrot
area
femor
head
assist
carm
xray
machin
necrot
tissu
remov
complet
cellhydrogel
composit
transplant
necrot
area
bone
tunnel
made
drill
group
iii
iv
bone
tunnel
seal
absorb
collagen
spong
plug
wound
close
layer
follow
oper
anim
receiv
gentamicin
muday
shanghai
biochem
pharmaceut
co
ltd
shanghai
china
intramuscularli
prophylaxi
day
anim
free
move
four
week
surgeri
anim
anesthet
intraven
pentobarbit
abdomin
caviti
rabbit
open
syring
needl
insert
abdomin
aorta
distal
heart
abdomin
aorta
proxim
heart
ligat
abdomin
vein
cut
open
heparin
normal
salin
shanghai
biochem
pharmaceut
co
ltd
inject
vasculatur
needl
flow
speed
mmmin
outflow
limpid
silicon
inject
compound
microfil
flow
tech
inc
carver
usa
pump
vasculatur
femor
head
anim
store
ensur
polymer
contrast
agent
h
proxim
part
femur
harvest
fix
paraformaldehyd
evalu
bone
regener
necrot
area
femor
head
sampl
scan
microct
scan
perform
use
microct
scanner
skyscan
bruker
microct
kontich
belgium
resolut
follow
set
anod
current
xray
voltag
kvp
exposur
time
msec
bone
tissu
defin
threshold
hounsfield
unit
hu
necrot
area
femor
head
select
region
interest
roi
aid
preoper
mri
paramet
bone
volumetot
volum
bvtv
bone
miner
densiti
bmd
roi
calcul
indic
bone
regener
necrot
area
sampl
decalcifi
ethylenediaminetetraacet
acid
sinopharm
chemic
reagent
co
ltd
shanghai
china
week
follow
decalcif
sampl
underw
microct
examin
resolut
per
voxel
evalu
vascular
necrot
area
segment
vessel
background
nois
remov
low
pass
gaussian
filter
vessel
defin
threshold
hu
reconstruct
threedimension
architectur
blood
vessel
necrot
area
vessel
includ
twodimension
section
builtin
contour
program
automat
reconstruct
threedimension
imag
axial
slice
sampl
visual
volum
vessel
necrot
area
calcul
histolog
immunohistochemistri
microct
scan
sampl
dehydr
made
transpar
use
dimethylbenzen
sinopharm
chemic
reagent
co
ltd
embed
wax
section
coron
plane
section
stain
hematoxylin
eosin
h
e
observ
light
microscop
leica
microsystem
gmbh
wetzlar
germani
imagepro
plu
softwar
media
cybernet
inc
rockvil
md
usa
use
evalu
new
bone
format
magnif
six
randomli
select
field
per
section
bone
densiti
defin
ratio
new
bone
area
total
area
border
new
bone
osteoid
tissu
difficult
defin
osteoid
tissu
includ
new
bone
calcul
immunohistochemistri
perform
use
antibodi
specif
abcam
abcam
brief
section
rehydr
incub
primari
antibodi
overnight
incub
biotinyl
secondari
igg
wuhan
boster
biolog
technolog
ltd
wuhan
china
section
treat
abc
complex
develop
wuhan
boster
biolog
technolog
ltd
stain
hematoxylin
section
consist
maintain
liquid
section
incub
without
primari
antibodi
use
control
statist
analysi
data
express
mean
standard
deviat
oneway
analysi
varianc
studentnewmankeul
post
hoc
analysi
appli
determin
statist
signific
p
consid
indic
statist
signific
differ
statist
analysi
perform
use
spss
softwar
version
spss
inc
chicago
il
usa
overexpress
rabbit
asc
western
blot
analysi
perform
detect
protein
express
rabbit
asc
treat
differ
concentr
dmog
data
show
express
protein
increas
respons
dmog
treatment
dosedepend
manner
fig
treatment
day
express
cell
respect
increas
dmog
respect
compar
untreat
asc
treatment
day
level
protein
asc
signific
differ
compar
asc
treat
dmog
day
indic
dmog
could
enhanc
express
least
day
bone
regener
necrot
area
group
initi
analyz
use
microct
scan
bone
microarchitectur
group
reconstruct
three
dimens
present
fig
sampl
group
receiv
treatment
show
destroy
trabecula
necrot
area
femor
head
group
ii
receiv
core
decompress
trabecula
necrot
area
thin
spars
group
iii
receiv
core
decompress
transplant
normal
asc
trabecula
necrot
area
intact
group
iv
receiv
core
decompress
transplant
dmog
treat
asc
trabecula
necrot
area
appear
intact
well
distribut
quantit
analysi
indic
nearli
new
bone
format
necrot
area
group
fig
contrast
necrot
area
regener
group
ii
group
iii
group
iv
bmd
new
bone
necrot
area
group
iv
also
significantli
higher
three
group
p
bone
regener
necrot
area
group
also
evalu
use
h
e
stain
group
numer
fat
cell
rare
trabecular
tissu
necrot
area
numer
empti
lacuna
distribut
along
trabecula
fig
group
ii
less
granul
tissu
fewer
fat
cell
necrot
area
empti
lacuna
observ
fig
group
iii
disord
trabecular
tissu
necrot
area
obvious
group
ii
fig
group
iv
substanti
trabecular
tissu
larg
osteocyt
distribut
along
trabecula
fig
histomorphometr
analysi
confirm
new
bone
group
iv
three
group
consist
microct
data
p
fig
vascular
necrot
area
group
four
week
surgeri
evalu
perfus
blood
vessel
silicon
inject
compound
imag
microct
reconstruct
three
dimension
imag
show
morpholog
regener
vessel
necrot
area
group
nearli
vascular
architectur
necrot
area
fig
group
ii
blood
vessel
observ
fig
group
iii
densiti
vessel
significantli
higher
group
ii
fig
group
iv
larg
vessel
obvious
increas
compar
three
group
fig
quantit
analysi
also
show
averag
number
volum
blood
vessel
penetr
necrot
area
group
iv
significantli
three
group
p
fig
addit
immunohistochemistri
perform
evalu
newli
form
vessel
necrot
area
blood
vessel
defin
posit
stain
typic
round
oval
structur
result
show
vessel
group
iv
three
group
support
microct
result
fig
immunohistochemistri
perform
evalu
express
asc
vivo
fig
group
ii
iii
obviou
cell
observ
necrot
area
howev
posit
cell
appar
group
iv
indic
sustain
releas
dmog
could
enhanc
express
asc
vivo
corticosteroidinduc
onfh
major
type
onfh
seriou
complic
corticosteroid
treatment
autoimmun
diseas
system
lupu
erythematosu
nephrot
syndrom
rheumatoid
arthriti
diagnost
therapeut
strategi
onfh
best
introduc
earli
stage
diseas
becom
irrevers
current
treatment
method
earlystag
onfh
highli
controversi
core
decompress
report
effect
earlystag
onfh
act
revers
natur
process
onfh
provid
conduit
angiogenesi
revascular
subchondr
bone
reduc
elev
intraoss
pressur
howev
major
studi
effect
core
decompress
suggest
result
approach
satisfactori
asept
necrot
bone
femor
head
retain
normal
strength
natur
process
revascular
start
remov
dead
bone
prepar
format
new
bone
repair
advanc
speed
angiogenesi
osteogenesi
becom
slower
absorpt
dead
bone
may
caus
weaken
mechan
structur
jone
hypothes
new
capillari
could
penetr
mm
necrot
bone
subchondr
bone
tissu
usual
repair
furthermor
microfractur
subchondr
bone
may
retard
capillari
penetr
load
area
would
collaps
thu
import
onfh
treatment
increas
local
vascular
new
bone
format
report
msc
pool
femor
head
could
provid
enough
osteoblast
meet
need
local
bone
regener
research
also
suggest
msc
proxim
femur
decreas
prolif
differenti
capac
earli
stage
onfh
therefor
msc
employ
aid
core
decompress
treat
earlystag
onfh
hypoxia
induc
import
function
subunit
hif
famili
crucial
mediat
adapt
cell
respons
hypoxia
aros
earli
evolut
wide
express
human
tissu
previou
studi
found
control
express
numer
gene
cell
cell
prolifer
differenti
previou
studi
show
compar
normal
msc
transgen
msc
improv
osteogen
angiogen
capac
vitro
better
potenti
promot
bone
regener
necrot
area
femor
head
howev
risk
gene
transduct
tumorigenesi
perman
overexpress
transduc
gene
limit
clinic
applic
overcom
defici
present
studi
dimethyloxaloylglycin
dmog
cell
permeabl
inhibitor
employ
enhanc
express
msc
place
gene
transduct
dmog
small
molecular
drug
abl
stabil
express
cell
normal
oxygen
tension
modifi
oxygen
depend
prolyl
hydroxylas
result
rapid
degrad
ubiquitinproteasom
pathway
hypox
condit
prolyl
hydroxylas
activ
decreas
stabil
dmog
abl
inhibit
prolyl
hydroxylas
activ
normal
oxygen
tension
thu
lead
overexpress
cell
dmog
use
treat
ischem
skelet
muscl
middl
cerebr
arteri
occlus
ischem
myocardi
injuri
result
good
outcom
previou
experi
previou
studi
show
dmog
could
significantli
enhanc
vegf
product
asc
improv
osteogen
differenti
potenti
asc
vitro
stabil
express
asc
dmogtreat
asc
increas
bone
heal
capac
promot
local
revascular
critic
defect
present
studi
investig
efficaci
implant
dmogtreat
asc
treat
earlystag
corticosteroidinduc
onfh
studi
use
rabbit
model
steroidinduc
earlystag
onfh
anim
model
onfh
import
evalu
effect
variou
method
treat
onfh
present
model
osteonecrosi
induc
combin
lp
mp
mimic
patholog
mechan
steroidinduc
onfh
report
induct
protocol
high
incid
onfh
result
nearli
death
suggest
numer
histopatholog
pathogenet
featur
steroidinduc
onfh
rabbit
similar
observ
human
earlystag
onfh
therefor
steroidinduc
rabbit
onfh
model
may
effect
test
efficaci
method
develop
treatment
steroidassoci
onfh
clinic
applic
confirm
longterm
effect
prevent
subchondr
bone
collaps
hip
present
studi
dmogtreat
asc
implant
necrot
area
femor
head
aid
core
decompress
improv
bone
heal
microct
histolog
result
indic
increas
bone
regener
normal
asc
group
group
underw
core
decompress
suggest
asc
could
improv
bone
heal
increas
newli
form
bone
observ
dmogtreat
asc
group
normal
asc
group
indic
dmog
could
enhanc
bone
heal
capac
asc
necrot
area
microct
immunohistochemistri
detect
show
vessel
format
also
increas
dmogtreat
asc
group
three
group
may
dmog
could
increas
express
secret
certain
angiogen
factor
asc
vivo
stabil
express
cell
demonstr
previou
experi
hypothes
angiogenesi
close
associ
osteogenesi
neovascular
favor
element
bone
regener
therefor
improv
local
blood
suppli
may
also
contribut
bone
heal
necrot
area
summari
result
present
studi
show
dmogtreat
asc
markedli
increas
vascular
bone
regener
necrot
area
femor
head
onfh
rabbit
find
suggest
dmog
could
enhanc
osteogen
activ
asc
vivo
may
therefor
provid
novel
effect
therapeut
option
earlystag
corticosteroidinduc
onfh
